These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 22868231)
21. Effect of nonpolar substitutions of the conserved Phe11 in the fusion peptide of HIV-1 gp41 on its function, structure, and organization in membranes. Pritsker M; Rucker J; Hoffman TL; Doms RW; Shai Y Biochemistry; 1999 Aug; 38(35):11359-71. PubMed ID: 10471286 [TBL] [Abstract][Full Text] [Related]
22. Characterization of the interaction of two peptides from the N terminus of the NHR domain of HIV-1 gp41 with phospholipid membranes. Moreno MR; Guillén J; Pérez-Berna AJ; Amorós D; Gómez AI; Bernabeu A; Villalaín J Biochemistry; 2007 Sep; 46(37):10572-84. PubMed ID: 17711304 [TBL] [Abstract][Full Text] [Related]
23. Interaction of GB virus C/hepatitis G virus synthetic peptides with lipid langmuir monolayers and large unilamellar vesicles. Pérez-López S; Vila-Romeu N; Asunción Alsina Esteller M; Espina M; Haro I; Mestres C J Phys Chem B; 2009 Jan; 113(1):319-27. PubMed ID: 19195104 [TBL] [Abstract][Full Text] [Related]
24. A computational approach identifies two regions of Hepatitis C Virus E1 protein as interacting domains involved in viral fusion process. Bruni R; Costantino A; Tritarelli E; Marcantonio C; Ciccozzi M; Rapicetta M; El Sawaf G; Giuliani A; Ciccaglione AR BMC Struct Biol; 2009 Jul; 9():48. PubMed ID: 19640267 [TBL] [Abstract][Full Text] [Related]
25. Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection. Herrera E; Tenckhoff S; Gómara MJ; Galatola R; Bleda MJ; Gil C; Ercilla G; Gatell JM; Tillmann HL; Haro I J Med Chem; 2010 Aug; 53(16):6054-63. PubMed ID: 20718496 [TBL] [Abstract][Full Text] [Related]
26. The minimal fusion peptide of simian immunodeficiency virus corresponds to the 11 first residues of gp32. Lorin A; Lins L; Stroobant V; Brasseur R; Charloteaux B J Pept Sci; 2008 Apr; 14(4):423-8. PubMed ID: 17994611 [TBL] [Abstract][Full Text] [Related]
27. Synthetic peptides derived from an N-terminal domain of the E2 protein of GB virus C in the study of GBV-C/HIV-1 co-infection. Fernández L; Chan WC; Egido M; Gómara MJ; Haro I J Pept Sci; 2012 May; 18(5):326-35. PubMed ID: 22438139 [TBL] [Abstract][Full Text] [Related]
28. Interaction of arginine oligomer with model membrane. Yi D; Guoming L; Gao L; Wei L Biochem Biophys Res Commun; 2007 Aug; 359(4):1024-9. PubMed ID: 17572387 [TBL] [Abstract][Full Text] [Related]
29. Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion. Dimitrov AS; Rawat SS; Jiang S; Blumenthal R Biochemistry; 2003 Dec; 42(48):14150-8. PubMed ID: 14640682 [TBL] [Abstract][Full Text] [Related]
30. Characterization of the interacting domain of the HIV-1 fusion peptide with the transmembrane domain of the T-cell receptor. Cohen T; Pevsner-Fischer M; Cohen N; Cohen IR; Shai Y Biochemistry; 2008 Apr; 47(16):4826-33. PubMed ID: 18376816 [TBL] [Abstract][Full Text] [Related]
31. Interaction of fusogenic synthetic peptide with phospholipid bilayers: orientation of the peptide alpha-helix and binding isotherm. Ishiguro R; Matsumoto M; Takahashi S Biochemistry; 1996 Apr; 35(15):4976-83. PubMed ID: 8664290 [TBL] [Abstract][Full Text] [Related]
32. Behaviour of a peptide sequence from the GB virus C/hepatitis G virus E2 protein in Langmuir monolayers: its interaction with phospholipid membrane models. Pérez-López S; Nieto-Suárez M; Mestres C; Alsina MA; Haro I; Vila-Romeu N Biophys Chem; 2009 May; 141(2-3):153-61. PubMed ID: 19232456 [TBL] [Abstract][Full Text] [Related]
33. The HIV fusion peptide adopts intermolecular parallel beta-sheet structure in membranes when stabilized by the adjacent N-terminal heptad repeat: a 13C FTIR study. Sackett K; Shai Y J Mol Biol; 2005 Jul; 350(4):790-805. PubMed ID: 15964015 [TBL] [Abstract][Full Text] [Related]
35. Cooperative effects in phospholipid monolayers induced by a peptide from HIV-1 capsid protein. Moraes ML; Bonardi C; Mendonça CR; Campana PT; Lottersberger J; Tonarelli G; Oliveira ON; Beltramini LM Colloids Surf B Biointerfaces; 2005 Mar; 41(1):15-20. PubMed ID: 15698751 [TBL] [Abstract][Full Text] [Related]
36. Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV. Gustchina E; Hummer G; Bewley CA; Clore GM J Med Chem; 2005 Apr; 48(8):3036-44. PubMed ID: 15828842 [TBL] [Abstract][Full Text] [Related]
37. Membrane binding and structure of de novo designed alpha-helical cationic coiled-coil-forming peptides. Vagt T; Zschörnig O; Huster D; Koksch B Chemphyschem; 2006 Jun; 7(6):1361-71. PubMed ID: 16680794 [TBL] [Abstract][Full Text] [Related]
38. Structural constraints imposed by the conserved fusion peptide on the HIV-1 gp41 epitope recognized by the broadly neutralizing antibody 2F5. de la Arada I; Julien JP; de la Torre BG; Huarte N; Andreu D; Pai EF; Arrondo JL; Nieva JL J Phys Chem B; 2009 Oct; 113(41):13626-37. PubMed ID: 19754136 [TBL] [Abstract][Full Text] [Related]
39. Structural analysis and assembly of the HIV-1 Gp41 amino-terminal fusion peptide and the pretransmembrane amphipathic-at-interface sequence. Lorizate M; de la Arada I; Huarte N; Sánchez-Martínez S; de la Torre BG; Andreu D; Arrondo JL; Nieva JL Biochemistry; 2006 Dec; 45(48):14337-46. PubMed ID: 17128972 [TBL] [Abstract][Full Text] [Related]
40. Interaction of a peptide derived from the N-heptad repeat region of gp41 Env ectodomain with model membranes. Modulation of phospholipid phase behavior. Pascual R; Contreras M; Fedorov A; Prieto M; Villalaín J Biochemistry; 2005 Nov; 44(43):14275-88. PubMed ID: 16245944 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]